Favorable Long-Term Outcomes of One-Year Adjuvant S-1 Monotherapy for Pathological Stage II or III Gastric Cancer Treated at a High-Volume Center
Gastric Cancer - Germany
doi 10.1007/s10120-018-0827-9
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2018
Authors
Publisher
Springer Science and Business Media LLC